4 articles about Ansa Biotechnologies
Ansa Biotechnologies Announces First Shipments of Complex Clonal DNA Sequences to Customers in its Early Access Program
Ansa Biotechnologies, Inc will present more information regarding these milestones at the SynBioBeta conference on Wednesday, May 24, 2023, at 11:46 a.m. PT.
Ansa Biotechnologies Announces Successful de novo Synthesis of World’s Longest Oligonucleotide at 1005 Bases
Ansa Biotechnologies, Inc today announced the successful de novo synthesis of the world’s longest DNA oligonucleotide ever reported to be produced in a single synthesis.
Ansa Biotechnologies today announced the appointment of Matthew F. McManus, M.D, Ph.D., as Independent Director and Chairperson of the company’s Board of Directors.
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.